Figures computed from official regulatory filings — .
Analysttarget 2 USD (+1049%) · consensus 3/5 · 0 buy · 1 hold · 0 sell
Ownershipinsiders 14.02% · institutions 13.67% · short 2.4% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for NEXGEL, INC. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments: Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications; and beauty and cosmetic solutions. It also develops NEXDrape, an incise surgical drape designed for patients with impaired skin; and NEXDerm, an adhesive tape designed to secure central lines and intravenous tubes and devices to patients before, during, and after medical treatment. In addition, the company engages in the converting and packaging business. It serves its customers under Medagel, Kenkoderm and Silly George brand names. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was incorporated in 2009 and is based in Langhorne, Pennsylvania.
Market information source · Oct 5, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 5, 2026
Open-market timeline · full history
62 buys35 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details |
|---|---|---|---|---|
| Levy Adam R. | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Levy Adam R. | Sell | $3K | SEC |
| Levy Adam R. | Sell | $3.6K | SEC |
| Levy Adam R. | Sell | $1.8K | SEC |
| Levy Adam R. | Sell | $1.6K | SEC |
| Levy Adam R. | Sell | $1.8K | SEC |
| Levy Adam R. | Sell | $1.2K | SEC |
| Levy Adam R. | Sell | $1.8K | SEC |
| Levy Adam R. | Sell | $4.2K | SEC |
| Levy Adam R. | Sell | $1.8K | SEC |
| Kieser Brian Joseph | BuyD (derivative) | $1M | First in 12mo | SEC |
| Levy Adam R. | BuyD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | ClusterFirst in 12mo | SEC |
| Henry Scott Roberttrack record | BuyD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | ClusterFirst in 12mo | SEC |
| Kieser Brian Joseph | BuyD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | First in 12mo | SEC |
| Henry Scott Roberttrack record | BuyD (derivative) | $25K | ClusterFirst in 12mo | SEC |
| Levy Adam R. | BuyD (derivative) | $60K | ClusterFirst in 12mo | SEC |
| Levy Adam R. | Sell | $9.7K | SEC |
| Levy Adam R. | Sell | $6.3K | SEC |
| Levy Adam R. | Sell | $10.1K | SEC |
| Levy Adam R. | Sell | $4K | SEC |
| Henry Scott Roberttrack record | Sell | $18.3K | SEC |
| Levy Adam R. | Sell | $6.1K | SEC |
| Henry Scott Roberttrack record | Sell | $2.1K | Unusual size | SEC |
| Henry Scott Roberttrack record | Sell | $18.2K | Unusual size | SEC |
| Levy Adam R. | Sell | $9.9K | SEC |